These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27092576)

  • 1. Subanesthetic, Subcutaneous Ketamine Infusion Therapy in the Treatment of Chronic Nonmalignant Pain.
    Zekry O; Gibson SB; Aggarwal A
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):91-8. PubMed ID: 27092576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Ketamine Infusion for Emergency Department Patients with Severe Pain.
    Ahern TL; Herring AA; Miller S; Frazee BW
    Pain Med; 2015 Jul; 16(7):1402-9. PubMed ID: 25643741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine decreases postoperative pain scores in patients taking opioids for chronic pain: results of a prospective, randomized, double-blind study.
    Barreveld AM; Correll DJ; Liu X; Max B; McGowan JA; Shovel L; Wasan AD; Nedeljkovic SS
    Pain Med; 2013 Jun; 14(6):925-34. PubMed ID: 23786558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.
    Rakhman E; Shmain D; White I; Ekstein MP; Kollender Y; Chazan S; Dadia S; Bickels J; Amar E; Weinbroum AA
    Clin Ther; 2011 Jul; 33(7):863-73. PubMed ID: 21722959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
    Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
    Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of sublingual ketamine troches/lozenges in chronic non-malignant pain management.
    Maudlin B; Gibson SB; Aggarwal A
    Intern Med J; 2022 Sep; 52(9):1538-1543. PubMed ID: 34092024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine as a potential option in the treatment of short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing.
    Aggarwal A
    Natl Med J India; 2019; 32(2):86-87. PubMed ID: 31939403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a subanesthetic infusion of intravenous ketamine to allow withdrawal of medically prescribed opioids in people with chronic pain, opioid tolerance and hyperalgesia: outcome at 6 months.
    Quinlan J
    Pain Med; 2012 Nov; 13(11):1524-5. PubMed ID: 22978408
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.
    Patil S; Anitescu M
    Pain Med; 2012 Feb; 13(2):263-9. PubMed ID: 21939497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements.
    Kapural L; Kapural M; Bensitel T; Sessler DI
    Pain Physician; 2010; 13(4):389-94. PubMed ID: 20648208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion ("Burst Ketamine") in Diabetic Neuropathic Rats.
    Mak P; Broadbear JH; Kolosov A; Goodchild CS
    Pain Med; 2015 Sep; 16(9):1781-93. PubMed ID: 25800174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
    Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
    Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Tolerability of Oral Compared with Sublingual Ketamine Lozenges as Rescue Analgesics in Adults for Acute Pain: The OSKet Trial.
    Chong CC; Schug SA
    Clin Drug Investig; 2021 Sep; 41(9):817-823. PubMed ID: 34368943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5-year study of 51 patients.
    Marchetti F; Coutaux A; Bellanger A; Magneux C; Bourgeois P; Mion G
    Eur J Pain; 2015 Aug; 19(7):984-93. PubMed ID: 25381898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study.
    Sheehy KA; Muller EA; Lippold C; Nouraie M; Finkel JC; Quezado ZM
    BMC Pediatr; 2015 Dec; 15():198. PubMed ID: 26620833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine as an Adjunct to Opioids for Acute Pain in the Emergency Department: A Randomized Controlled Trial.
    Bowers KJ; McAllister KB; Ray M; Heitz C
    Acad Emerg Med; 2017 Jun; 24(6):676-685. PubMed ID: 28177167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early and delayed analgesic effects of ketamine after total hip arthroplasty: a prospective, randomized, controlled, double-blind study.
    Remérand F; Le Tendre C; Baud A; Couvret C; Pourrat X; Favard L; Laffon M; Fusciardi J
    Anesth Analg; 2009 Dec; 109(6):1963-71. PubMed ID: 19923527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain.
    Chebini A; Marzoughi S; Randhawa J; Guh D; Wiseman S; Fedoroff I; Ong M
    Pain Manag; 2022 Apr; 12(3):337-346. PubMed ID: 34528840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.